Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation

Transplantation

Volumn 62, Issue 3, 1996, Pages 376-380

  Bacigalupo, A ^a   Bregante, S ^a   Tedone, E ^a   Isaza, A ^a   Van Lint, M T ^a   Trespi, G ^a   Occhini, D ^a   Gualandi, F ^a   Lamparelli, T ^a   Marmont, Alberto M ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; CYCLOSPORIN; FOSCARNET; GANCICLOVIR;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CELL TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DOSE CALCULATION; DRUG EFFICACY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HYPOCALCEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; PRIORITY JOURNAL;

EID: 9444255768     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199608150-00013     Document Type: Article

References (20)

1. The Th, van der Ploeg M, van der Berg AP, Vlieger AM, van der Giessen M, van Son WJ. Direct detection of cytomegalovirus in peripheral blood leukocytes: a review of the antigenemia assay and polymerase chain reaction. Transplantation 1992; 54: 193.
2. Gerna G, Revello MG, Percivalle E, Zvattoni M, Parea M, Battaglia M. Qualification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. J CliN Microbiol 1990; 28: 2681.
3. Boeckh M, Bowden RA, Goodrich JM, Pettinger M, Meyerst JD: Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 1992; 80: 1358.
4. Bacigalupo A, Tedone E, Isaza A, et al. CMV-antigenemia after allogeneic bone marrow transplantation: correlation of CMV-antigen positive cell numbers with transplant-related mortality. Bone Marrow Transplant 1995; 16: 155.
5. Van Lint MT, Bacigalupo A, Frassoni F, et al. Bone marrow transplantation for acute lymphoblastic leukemia in remission. Haematologica 1986; 71: 337.
6. Bacigalupo A, van Lint MT, Occhini D, et al. Increased risk of leukemia relapse with high dose cyclosporine a (Cya) following allogeneic marrow transplantation for acute leukemia. Blood 1991; 77: 1423.
7. Bacigalupo A, Tedone E, Sanna MA, et al. CMV infections following allogeneic BMT: risk factors early treatment and correlation with transplant related mortality. Haematologica 1992; 77: 507.
8. Kaplan EL, Meier P. Non-parametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457.
9. Ljungman P, De Bock R, Cordonnier C, et al. Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Disease of the EBMT. Bone Marrow Transplant 1993; 12: 399.
10. Bowden RA. Antivirals for cytomegalovirus. In: Michelson S, Ploktin SA, eds. Multidisciplinary approach to understanding cytomegalovirus disease. Amsterdam: Excerpta Medica, 1993: 241.
11. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992; 326: 213.
12. Reusser P, Gambertoglio JG, Lilleby K, Meyers JD. Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients. J Infect Dis 1992; 166: 473.
13. Bacigalupo A, van Lint MT, Tedone E, et al. Early treatment of CMV infections in allogeneic bone marrow transplant recipients with foscarnet or ganciclovir. Bone Marrow Transplant 1994; 13: 753.
14. Ljiungman P, Griffiths P. Definitions of cytomegalovirus infection and disease. In: Michelson S, Plotkin SA, eds. Multidisciplinary approach to understanding cytomegalovirus disease. Amsterdam: Excerpta Medica, 1993: 233.
15. Ferrara JLM, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324: 10.
16. Dieterich DT, Poles MA, Lew EA, et al. Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients. J Infect Dis 1993; 167: 1184.
17. Goodrich JM, Mori M, Gleaves CA, et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after bone marrow transplantation: risk factors for cytomegalovirus infection after human marrow transplantation. N Engl J Med 1991; 325: 161.
18. Tanaka K, Koga Y, Yi-Yu LU, et al. Murine cytomegalovirus-associated pneumonitis in the lungs free of the virus. J Clin Invest 1994; 94: 1019.
19. Ferrara JLM. Paradigm shift for graft-versus-host disease. Bone Marrow Transplant 1994; 14: 183.
20. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005.